Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115810) titled 'No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort' on Aug. 4.

Study Type: Observational

Primary Sponsor: King Faisal Specialist Hospital & Research Center

Condition: Differentiated Thyroid Cancer

Intervention: Other: No additional drugs(control Group)

Recruitment Status: Not recruiting

Date of First Enrollment: January 1, 1988

Target Sample Size: 178

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07115810

Published by HT Digital Content Services with permission from Health Daily Digest....